Skip to search formSkip to main contentSkip to account menu

dronedarone

Known as: N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide, N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (1)

Amiodarone
Anti-Arrhythmia Agentsanalogs & derivativesdronedarone 400 MG Oral Tablet [Multaq]

Narrower (3)

Dronedarone HydrochlorideMultaqSR 33589

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
2012
2012
Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
2012
2012
Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs
Atrial fibrillation induces ischaemic microcirculatory flow abnormalities in the ventricle, contributing to the risk for acute… 
Review
2012
Review
2012
Dronedarone for the Treatment of Atrial Fibrillation
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of dronedarone (Multaq®, Sanofi-Aventis… 
2011
2011
Comparing the 2010 North American and European atrial fibrillation guidelines.
2011
2011
Acute liver failure associated with dronedarone.
A 70-year-old woman was initially referred to a community hospital for progressive fatigue and hyperbilirubinemia for 2 weeks… 
2011
2011
Realtime fusion of cardiac magnetic resonance imaging and computed tomography venography with X-ray fluoroscopy to aid cardiac resynchronisation therapy implantation in patients with persistent left…
Persistent left superior vena cava can lead to significant technical difficulties when implanting a left ventricular (LV) lead… 
2010
2010
Suppression of Ventricular Tachycardia With Dronedarone: A Case Report
Suppression of Ventricular Tachycardia With Dronedarone. Introduction: Dronedarone is a multichannel blocker with similar… 
Review
2008
Review
2008
New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
Review
2008
Review
2008
Pharmacotherapy for atrial arrhythmias: present and future.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)